Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06642597 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

STarting incrEmental Prescription of Peritoneal Dialysis

Study acronym: STEP-PD
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial sites expanded: 9 → 14 locations
    • Eligibility criteria expanded, about 6 words
    • Secondary endpoints: details revised at 2 of 9 entries
  2. Trial sites expanded: 6 → 9 locationsv5
  3. Study sites: 4 to 6v4
  4. Study sites: 3 to 4v3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Mar 1, 2025 to Sep 19, 2025
    • Study sites: 1 to 3
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Kidney failure is fatal without dialysis. Peritoneal dialysis (PD) completed at home offers greater flexibility and autonomy for patients . However, PD is often prescribed for 24 hours/day, 7 days/week for every patient starting dialysis. This practice is not evidence-informed, may be unnecessary and potentially harmful. The STEP-PD trial aims to determine the optimal approach to commencing patients on PD through starting at low dose PD and incrementing over time.
Trial Details
NCT Number NCT06642597
Lead Sponsor The University of Queensland
Conditions
(from sponsor)		 Peritoneal Dialysis (PD), Kidney Failure
Related terms Kidney Diseases, Renal Insufficiency
Enrollment 224 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov